Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the C-Early Ra ...
Abstract
Authors
P Emery C Bingham G Burmester V Bykerk D Furst X Mariette O Purcaru G Coteur B Vanlunen M Weinblatt